Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114507180A reveals an iodine-catalyzed method for synthesizing bis-heteroaryl ethylenes with 90% yield, offering a metal-free route for reliable pharmaceutical intermediate suppliers.
Patent CN114634481B reveals copper-mediated method improving substrate scope. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN114315906B discloses novel chiral phosphite ligands enabling high-yield asymmetric hydrosilylation and hydroformylation for reliable pharmaceutical intermediate supplier networks.
Patent CN105085419A details novel catalytic method ensuring high purity and scalable production for reliable pharmaceutical intermediate supply chains globally.
Patent CN115850240B reveals a two-step route for Olutasidenib. This method ensures high purity and supply chain stability for pharmaceutical manufacturers.
Patent CN108752290B details a high-yield TTP/HFIP catalytic route for benproperine phosphate, offering significant cost reduction and purity improvements for API manufacturers.
Patent CN103214407B details silver-catalyzed sp3 C-H amination for tetrahydropyrrole derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel photocatalytic synthesis of chiral alpha,alpha-diaryl ketones overcomes racemization. Ideal for API intermediates. Cost-effective scale-up and reliable supply.
Patent CN104797563B reveals improved in-situ synthesis of activated fumarate intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical excipient manufacturing.
Patent CN106631823B details a safe, cost-effective synthesis of lorcaserin intermediates using sodium borohydride reduction, eliminating toxic borane and expensive reagents.
Novel metal-free synthesis of functionalized allenones using N-heterocyclic carbene catalysts. Offers high atom economy and scalability for pharmaceutical intermediates.
Discover a catalyst-free thermal method for synthesizing alpha-amidoketones from patent CN111960961B. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN118108623A reveals mild base-catalyzed route for N-O bonds. Enables cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN110627693A reveals efficient allyl sulfone synthesis. Enables cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN111793017A details a safe ruthenium-catalyzed transfer hydrogenation method for high-ee lactams, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN114369053B reveals a metal-free route for high-purity sulfonylated pyrrolidone. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102558004A reveals a mild, high-yield synthesis route for S-(4-tolyl)benzenesulfonate, offering significant cost reduction and supply chain stability for fine chemical manufacturing.
Patent CN105153020A details a novel four-step synthesis route for aromatic azides offering significant cost reduction and enhanced supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthetic route for 7-chloro-2,2-dimethylheptanoate using 1-bromo-5-chloropentane. Achieves high purity, minimizes byproducts, and enables scalable manufacturing for lipid-lowering APIs.
Novel I2O5-mediated cyclization of diynes offers high-purity indanones with reduced environmental impact and simplified purification for pharmaceutical intermediates.